Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 50090-3576

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 50090-3576). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500903576)

FDA Label Image

Figure-1 (Valsartan Hctz Figure 1)

Figure-1 (Valsartan Hctz Figure 1)
This is a medical record that includes information about blood pressure medications. It appears to show different dosages of medication and a placebo (control group) in relation to baseline systolic blood pressure readings.*
FDA Label Image

Figure-2 (Valsartan Hctz Figure 2)

Figure-2 (Valsartan Hctz Figure 2)
This appears to be a table showing blood pressure readings and medication dosages. The first line indicates that the diastolic blood pressure (DBP) is less than 90 mmHg. The next line shows the medication being taken, including Valsartan and Hydrochlorothiazide in specific dosages. The numbers in the following lines indicate the blood pressure readings before and after treatment, with a baseline reading of 105 mmHg.*
FDA Label Image

Figure-3 (Valsartan Hctz Figure 3)

Figure-3 (Valsartan Hctz Figure 3)
This is a medication table showing various dosages (in mg) of Valsartan and Hydrochlorothiazide for managing hypertension. The table also contains a placebo group and baseline systolic blood pressure (mmHg) measurements.*
FDA Label Image

Figure-4 (Valsartan Hctz Figure 4)

Figure-4 (Valsartan Hctz Figure 4)
This is a table that displays the baseline diastolic blood pressure (DBP) values in mmHg of participants in a clinical trial. The participants were assigned to different treatment groups and doses of medication, including Valsartan HCT 320/125mg, Valsartan 320mg, Hydrochlorothiazide 25mg, and placebo. The DBP values range from 95 to 105 mmHg.*
FDA Label Image

Hctz-stru (Valsartan Hctz Hydrochlorothiazide)

Hctz-stru (Valsartan Hctz Hydrochlorothiazide)
Not available.*
FDA Label Image

Valsartan-str (Valsartan Hctz Valsartan)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.